Details

Autor(en) / Beteiligte

• Tcheng, Matthew
• Roma, Alessia
• Ahmed, Nawaz
• Smith, Richard W.
• Jayanth, Preethi
• Minden, Mark D.
• Schimmer, Aaron D.
• Hess, David A.
• Hope, Kristin
• Rea, Kevin A.
• Akhtar, Tariq A.
• Bohrnsen, Eric
• D'Alessandro, Angelo
• Mohsen, Al-Walid
• Vockley, Jerry
• Spagnuolo, Paul A.

Titel

Very long chain fatty acid metabolism is required in acute myeloid leukemia

Ist Teil von

• Blood, 2021-06, Vol.137 (25), p.3518-3532

Ort / Verlag

United States: Elsevier Inc

Erscheinungsjahr

2021

Link zum Volltext

Quelle

EZB-FREE-00999 freely available EZB journals

Beschreibungen/Notizen

• Acute myeloid leukemia (AML) cells have an atypical metabolic phenotype characterized by increased mitochondrial mass, as well as a greater reliance on oxidative phosphorylation and fatty acid oxidation (FAO) for survival. To exploit this altered metabolism, we assessed publicly available databases to identify FAO enzyme overexpression. Very long chain acyl-CoA dehydrogenase (VLCAD; ACADVL) was found to be overexpressed and critical to leukemia cell mitochondrial metabolism. Genetic attenuation or pharmacological inhibition of VLCAD hindered mitochondrial respiration and FAO contribution to the tricarboxylic acid cycle, resulting in decreased viability, proliferation, clonogenic growth, and AML cell engraftment. Suppression of FAO at VLCAD triggered an increase in pyruvate dehydrogenase activity that was insufficient to increase glycolysis but resulted in adenosine triphosphate depletion and AML cell death, with no effect on normal hematopoietic cells. Together, these results demonstrate the importance of VLCAD in AML cell biology and highlight a novel metabolic vulnerability for this devastating disease. •Evidence from unbiased screens shows that very long chain fatty acid metabolism is critical to AML cell survival.•Genetic knockdown or inhibition of VLCAD leads to selective AML cell death, highlighting a unique AML-specific metabolic vulnerability. [Display omitted]